23andMe Investor Presentation Deck

(in $M, except percentages) Therapeutics Research and Development Expense Consumer and Research Services Total R&D Expense Amount $24 28 $52 Three Months Ended June 30, FY2023 Percentage of total R&D expense 46% 54% Amount $21 23 $44 FY2022 Percentage of total R&D expense 47% 53% Copyright © 2022 23and Me, Inc. YoY % Change 15% 20% 23andMe 52

View entire presentation